Showing results (151-160 of 469) with videos related to

Sort By:
Pageof 47
Breast Cancer Research : BCR|March 20, 2025
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesteroneJames N Ingle, Vera J Suman, Malvika H Solanki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 9, 2022
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen MetabolismEmily J Koubek, Sarah A Buhrow, Stephanie L Safgren, et al.
Academic Radiology|November 8, 2020
MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant ChemotherapySadia Choudhery, Daniel Gomez-Cardona, Christopher P Favazza, et al.
Breast Cancer Research and Treatment|January 1, 2018
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancerTufia C Haddad, Antonino D'Assoro, Vera Suman, et al.
Molecular Cancer Research : MCR|February 25, 2021
Development and Characterization of Novel Endoxifen-Resistant Breast Cancer Cell Lines Highlight Numerous Differences from Tamoxifen-Resistant ModelsCalley J Jones, Malayannan Subramaniam, Michael J Emch, et al.
Human Pathology|September 19, 2009
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancerSejal S Shah, Rhett P Ketterling, Matthew P Goetz, et al.
AJR. American Journal of Roentgenology|July 26, 2011
Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients' immediate response to radiofrequency ablation and cryoablationPaul G Thacker, Matthew R Callstrom, Timothy B Curry, et al.
Breast Cancer Research and Treatment|May 24, 2019
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapyZahraa Al-Hilli, Grace Choong, Michael G Keeney, et al.
The Oncologist|April 21, 2018
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic ExperienceZhaohui Jin, Cristobal T Sanhueza, Benny Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841Jan Franko, Qian Shi, Charles D Goldman, et al.
Pageof 47